Company / Free Cash Flow per Share
West Pharmaceutical Services Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$6.49
FY2025
5-year range
$3.25 / $6.49
FY2021-FY2025
Trend
+72.5%
vs FY2024
Sector context
#30 of 148
Health Care
What the data says
West Pharmaceutical Services's free cash flow per share of $6.49 is higher than 80% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $0.98 in FY2016 to $6.49 in FY2025.
Based on SEC 10-K filings.
6.49 in FY2025 with a 5-year CAGR of +21.2%. Top quartile in the Health Care sector.
Improved from $5.59 to $6.49 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +17.3%
- 5-Year CAGR
- +21.2%
- 10-Year CAGR
- -
Sector benchmark
+28.4% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 72.5% year-over-year.
- Ranks #30 out of 148 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.49 | +72.5% |
| FY2024 | $3.76 | -32.8% |
| FY2023 | $5.59 | +39.2% |
| FY2022 | $4.02 | +23.5% |
| FY2021 | $3.25 | +31.1% |
| FY2020 | $2.48 | -23.6% |
| FY2019 | $3.25 | +30.6% |
| FY2018 | $2.49 | +37.3% |
| FY2017 | $1.81 | +84.6% |
| FY2016 | $0.98 | +2.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026